| scholarly article | Q13442814 |
| P2093 | author name string | Kovacs B | |
| Kovacs I | |||
| Feher J | |||
| Papale A | |||
| Balacco Gabrieli C | |||
| Schveoller M | |||
| P2860 | cites work | A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 | Q24544001 |
| Fatty acid import into mitochondria | Q28138465 | ||
| An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration | Q28190470 | ||
| Reduced amplitude and delayed latency in foveal response of multifocal electroretinogram in early age related macular degeneration | Q28353971 | ||
| Biochemical functions of coenzyme Q10 | Q28611180 | ||
| What's wrong with Bonferroni adjustments | Q29615550 | ||
| Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation | Q30671842 | ||
| Drusen in age-related macular degeneration: pathogenesis, natural course, and laser photocoagulation-induced regression | Q30761426 | ||
| Coenzyme q10 prevents apoptosis by inhibiting mitochondrial depolarization independently of its free radical scavenging property. | Q30925904 | ||
| What is lost by digitizing stereoscopic fundus color slides for macular grading in age-related maculopathy and degeneration? | Q31034870 | ||
| Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third national health and nutrition examination survey | Q32066253 | ||
| Oxidative damage and protection of the RPE. | Q33837754 | ||
| Drug delivery to mitochondria: the key to mitochondrial medicine | Q33853014 | ||
| Essential fatty acids and the brain: possible health implications | Q33922356 | ||
| Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). | Q33977885 | ||
| Mitochondrial function in ischaemia and reperfusion of the ageing heart | Q34023052 | ||
| Age-related structural and functional changes of brain mitochondria. | Q34104048 | ||
| Omega-3 fatty acids in inflammation and autoimmune diseases | Q34164525 | ||
| A role for local inflammation in the formation of drusen in the aging eye. | Q34809064 | ||
| How mitochondrial damage affects cell function | Q34953719 | ||
| Neuronal degeneration and mitochondrial dysfunction | Q35060350 | ||
| Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration | Q35084405 | ||
| Short wavelength automated perimetry in age related maculopathy | Q35318053 | ||
| Multiple significance tests: the Bonferroni method | Q36901984 | ||
| Dietary fat and fish intake and age-related maculopathy | Q39531709 | ||
| Grading of age-related maculopathy for epidemiological studies: is digital imaging as good as 35-mm film? | Q39657492 | ||
| An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group | Q40440695 | ||
| A potential role for immune complex pathogenesis in drusen formation | Q41743141 | ||
| Dual involvement of coenzyme Q10 in redox signaling and inhibition of death signaling in the rat heart mitochondria | Q43567480 | ||
| Dietary fat and risk for advanced age-related macular degeneration | Q43694046 | ||
| Roles of long chain fatty acids and carnitine in mitochondrial membrane permeability transition | Q43764265 | ||
| Interactions of n-3 fatty acids with ion channels in excitable tissues | Q44152928 | ||
| Effects of acetyl-L-carnitine and myo-inositol on high-energy phosphate and membrane phospholipid metabolism in zebra fish: a 31P-NMR-spectroscopy study | Q44418149 | ||
| Studies on the metabolic fate of n-3 polyunsaturated fatty acids | Q44535894 | ||
| Mitotropic compounds for the treatment of age-related macular degeneration. The metabolic approach and a pilot study | Q44545983 | ||
| Drusen-Associated Degeneration in the Retina | Q44595290 | ||
| The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study | Q45260287 | ||
| The effect of dietary lipid changes on the fatty acid composition and function of liver, heart and brain mitochondria in the rat at different ages | Q48182574 | ||
| The Bowman lecture. Towards an understanding of age-related macular disease | Q48570003 | ||
| Age-related macular degeneration and antioxidant status in the POLA study. POLA Study Group. Pathologies Oculaires Liées à l'Age. | Q51560247 | ||
| Are antioxidants or supplements protective for age-related macular degeneration? | Q51596706 | ||
| Effect of long-term feeding with acetyl-L-carnitine on the age-related changes in rat brain lipid composition: a study by 31P NMR spectroscopy | Q57947551 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ubidecarenone | Q321285 |
| macular degeneration | Q27429789 | ||
| P304 | page(s) | 154-166 | |
| P577 | publication date | 2005-05-01 | |
| P1433 | published in | Ophthalmologica | Q15759092 |
| P1476 | title | Improvement of visual functions and fundus alterations in early age-related macular degeneration treated with a combination of acetyl-L-carnitine, n-3 fatty acids, and coenzyme Q10. | |
| P478 | volume | 219 |
| Q46502335 | A randomized, prospective, placebo-controlled clinical trial of a novel zinc-monocysteine compound in age-related macular degeneration |
| Q38171391 | A review on the role of L-carnitine in the management of tamoxifen side effects in treated women with breast cancer. |
| Q55691409 | Berberine Protects Human Retinal Pigment Epithelial Cells from Hydrogen Peroxide-Induced Oxidative Damage through Activation of AMPK. |
| Q21284507 | Do nutritional supplements have a role in age macular degeneration prevention? |
| Q35930987 | Dynamic Drusen Remodelling in Participants of the Nutritional AMD Treatment-2 (NAT-2) Randomized Trial |
| Q38865940 | Functional and Structural Benefits Induced by Omega-3 Polyunsaturated Fatty Acids During Aging |
| Q34234455 | Genetic basis of inherited macular dystrophies and implications for stem cell therapy. |
| Q90626363 | Integrated bioinformatics analysis of aberrantly-methylated differentially-expressed genes and pathways in age-related macular degeneration |
| Q34221905 | Mitochondrial dysfunction in retinal diseases |
| Q24186584 | Omega 3 fatty acids for preventing or slowing the progression of age-related macular degeneration |
| Q24197544 | Omega 3 fatty acids for preventing or slowing the progression of age-related macular degeneration |
| Q55919856 | Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease |
| Q89958068 | Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease |
| Q90307768 | Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease |
| Q92184649 | Protective effects of delphinidin against H2O2-induced oxidative injuries in human retinal pigment epithelial cells |
| Q24603957 | Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism |
| Q41853283 | The effect of L-carnitine treatment on levels of malondialdehyde and glutathione in patients with age related macular degeneration |
| Q42379723 | Topical Coenzyme Q10 demonstrates mitochondrial-mediated neuroprotection in a rodent model of ocular hypertension. |
| Q34366170 | Update on current and future novel therapies for dry age-related macular degeneration |
| Q79926756 | [Osmoprotection as a new therapeutic principle] |
| Q34081729 | n-3 polyunsaturated fatty acids supplementation enhances hippocampal functionality in aged mice. |
Search more.